EP1358616A2 - Systeme, verfahren und computerprogrammprodukte zum anleiten der auswahl einer therapeutischen behandlungsweise auf der grundlage des methylationsstatus der dna - Google Patents

Systeme, verfahren und computerprogrammprodukte zum anleiten der auswahl einer therapeutischen behandlungsweise auf der grundlage des methylationsstatus der dna

Info

Publication number
EP1358616A2
EP1358616A2 EP01992975A EP01992975A EP1358616A2 EP 1358616 A2 EP1358616 A2 EP 1358616A2 EP 01992975 A EP01992975 A EP 01992975A EP 01992975 A EP01992975 A EP 01992975A EP 1358616 A2 EP1358616 A2 EP 1358616A2
Authority
EP
European Patent Office
Prior art keywords
information
patient
knowledge base
therapeutic treatment
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01992975A
Other languages
English (en)
French (fr)
Inventor
Kurt Berlin
Alexander Olek
Christian Piepenbrock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Epigenomics AG
Original Assignee
Epigenomics AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epigenomics AG filed Critical Epigenomics AG
Publication of EP1358616A2 publication Critical patent/EP1358616A2/de
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
EP01992975A 2000-11-02 2001-11-02 Systeme, verfahren und computerprogrammprodukte zum anleiten der auswahl einer therapeutischen behandlungsweise auf der grundlage des methylationsstatus der dna Withdrawn EP1358616A2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US70530200A 2000-11-02 2000-11-02
US705302 2000-11-02
PCT/EP2001/012666 WO2002037398A2 (en) 2000-11-02 2001-11-02 Systems, methods and computer program products for guiding the selection of therapeutic treatment regimens

Publications (1)

Publication Number Publication Date
EP1358616A2 true EP1358616A2 (de) 2003-11-05

Family

ID=24832866

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01992975A Withdrawn EP1358616A2 (de) 2000-11-02 2001-11-02 Systeme, verfahren und computerprogrammprodukte zum anleiten der auswahl einer therapeutischen behandlungsweise auf der grundlage des methylationsstatus der dna

Country Status (5)

Country Link
EP (1) EP1358616A2 (de)
JP (1) JP2004517394A (de)
AU (1) AU2002221800A1 (de)
CA (1) CA2427624A1 (de)
WO (1) WO2002037398A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20012593A0 (fi) * 2001-12-28 2001-12-28 Pertti Laehteenmaeki Menetelmä ja järjestelmä ravitsemustietopalvelun järjestämiseksi
FI20021031A (fi) 2001-12-28 2003-06-29 Pertti Laehteenmaeki Ravintoautomaatti
WO2005024068A2 (en) 2003-09-05 2005-03-17 Sequenom, Inc. Allele-specific sequence variation analysis
US7608394B2 (en) * 2004-03-26 2009-10-27 Sequenom, Inc. Methods and compositions for phenotype identification based on nucleic acid methylation
EP2395098B1 (de) 2004-03-26 2015-07-15 Agena Bioscience, Inc. Basenspezifische Spaltung methylierungsspezifischer Amplifikationsprodukte in Kombination mit Massenanalyse
US7949545B1 (en) 2004-05-03 2011-05-24 The Medical RecordBank, Inc. Method and apparatus for providing a centralized medical record system
US7762181B2 (en) 2004-10-01 2010-07-27 Fonterra Co-Operative Group Limited Customised nutritional food and beverage dispensing system
CN101517581A (zh) * 2006-09-20 2009-08-26 皇家飞利浦电子股份有限公司 分子诊断决策支持系统
US20130268290A1 (en) * 2012-04-02 2013-10-10 David Jackson Systems and methods for disease knowledge modeling
KR20150113113A (ko) 2013-01-29 2015-10-07 몰레큘러 헬스 게엠베하 임상적 판단 지원을 위한 시스템 및 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985559A (en) * 1997-04-30 1999-11-16 Health Hero Network System and method for preventing, diagnosing, and treating genetic and pathogen-caused disease
US6081786A (en) * 1998-04-03 2000-06-27 Triangle Pharmaceuticals, Inc. Systems, methods and computer program products for guiding the selection of therapeutic treatment regimens
EP0976835B1 (de) * 1998-07-29 2003-07-09 Keygene N.V. Verfahren zur Erkennung von Nukleinsäuremethylierungen durch AFLP
DE19905082C1 (de) * 1999-01-29 2000-05-18 Epigenomics Gmbh Verfahren zur Identifikation von Cytosin-Methylierungsmustern in genomischen DNA-Proben
EP1176539A1 (de) * 2000-07-13 2002-01-30 Virology Networks B.V. Rechnergestütztes Entscheidungsunterstützungsverfahren zum Auswählen einer Arzneimitteltherapie für Patienten mit einer viralen Erkrankung

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO0237398A2 *

Also Published As

Publication number Publication date
CA2427624A1 (en) 2002-05-10
WO2002037398A2 (en) 2002-05-10
JP2004517394A (ja) 2004-06-10
WO2002037398A3 (en) 2003-08-21
AU2002221800A1 (en) 2002-05-15

Similar Documents

Publication Publication Date Title
US20050021240A1 (en) Systems, methods and computer program products for guiding selection of a therapeutic treatment regimen based on the methylation status of the DNA
Choi et al. Association between titin loss-of-function variants and early-onset atrial fibrillation
Roses An inherited variable poly-T repeat genotype in TOMM40 in Alzheimer disease
Pulst Genetic linkage analysis
Lappalainen et al. Linkage of antisocial alcoholism to the serotonin 5-HT1B receptor gene in 2 populations
Montaut et al. Assessment of a targeted gene panel for identification of genes associated with movement disorders
US20060136142A1 (en) Systems, methods and computer program products for guiding selection of a therapeutic treatment regimen based on the methylation status of the DNA
Sutherland et al. The association of interleukin 6 haplotype clades with mortality in critically ill adults
Qu et al. Genomic alterations important for the prognosis in patients with follicular lymphoma treated in SWOG study S0016
Becher et al. Oculopharyngeal muscular dystrophy in hispanic New Mexicans
KR101805597B1 (ko) 질병 관련 유전체 분석 서비스 방법
Garone et al. MPV17 mutations causing adult-onset multisystemic disorder with multiple mitochondrial DNA deletions
Hauser et al. Association of genetic variants with primary open-angle glaucoma among individuals with African ancestry
Dawes et al. Introducing pharmacogenetic testing with clinical decision support into primary care: a feasibility study
Topol et al. The genomics gold rush
WO2018045228A2 (en) Interpreting genomic results and providing targeted treatment options in cancer patients
JP2003021630A (ja) 臨床診断サービスを提供するための方法
US20220183571A1 (en) Predicting fractional flow reserve from electrocardiograms and patient records
Chen et al. Presence of alanine-to-valine substitutions in myofibrillogenesis regulator 1 in paroxysmal nonkinesigenic dyskinesia: confirmation in 2 kindreds
US20040236723A1 (en) Method and system for data evaluation, corresponding computer program product, and corresponding computer-readable storage medium
KR20200051714A (ko) Hla 조직 매칭 및 그에 관한 방법(hla tissue matching and methods therefor)
Mirshahi et al. A genome-first approach to characterize DICER1 pathogenic variant prevalence, penetrance, and phenotype
McCannel et al. Identification of candidate tumor oncogenes by integrative molecular analysis of choroidal melanoma fine-needle aspiration biopsy specimens
Arnett et al. Autosomal dominant progressive sensorineural hearing loss due to a novel mutation in the KCNQ4 gene
WO2002037398A2 (en) Systems, methods and computer program products for guiding the selection of therapeutic treatment regimens

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030509

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: EPIGENOMICS AG

17Q First examination report despatched

Effective date: 20070605

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20071016